These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 18957479)

  • 21. Moxifloxacin and torsade de pointes.
    Dale KM; Lertsburapa K; Kluger J; White CM
    Ann Pharmacother; 2007 Feb; 41(2):336-40. PubMed ID: 17284508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amisulpride deliberate self-poisoning causing severe cardiac toxicity including QT prolongation and torsades de pointes.
    Isbister GK; Murray L; John S; Hackett LP; Haider T; O'Mullane P; Gosselin S; Daly F
    Med J Aust; 2006 Apr; 184(7):354-6. PubMed ID: 16584372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Torsade de pointes complicating the treatment of bleeding esophageal varices: association with neuroleptics, vasopressin, and electrolyte imbalance.
    Faigel DO; Metz DC; Kochman ML
    Am J Gastroenterol; 1995 May; 90(5):822-4. PubMed ID: 7733096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of bromocriptine in the treatment of amisulpride-induced hyperprolactinemia: a case report.
    Bliesener N; Yokusoglu H; Quednow BB; Klingmüller D; Kühn KU
    Pharmacopsychiatry; 2004 Jul; 37(4):189-91. PubMed ID: 15467977
    [No Abstract]   [Full Text] [Related]  

  • 25. Improvement of tardive dyskinesia following amisulpride treatment.
    Peritogiannis V; Tsouli S; Zafiris S; Pappas D; Mavreas V
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):748-50. PubMed ID: 16574293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Arrhythmogenic effects of sultopride chlorhydrate: clinical and cellular electrophysiological correlation].
    Lande G; Drouin E; Gauthier C; Chevallier JC; Godin JF; Chiffoleau A; Le Marec H
    Ann Fr Anesth Reanim; 1992; 11(6):629-35. PubMed ID: 1363741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Torsade de pointes following intravenous haloperidol administration in a patient with complete heart block.
    Ginwalla M; Biblo LA; Paydak H
    WMJ; 2009 Feb; 108(1):48-50. PubMed ID: 19326637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperprolactinemia after low dose of amisulpride.
    Kopecek M; Bares M; Svarc J; Dockery C; Horácek J
    Neuro Endocrinol Lett; 2004 Dec; 25(6):419-22. PubMed ID: 15665803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ciprofloxacin-induced torsade de pointes.
    Flanagan MC; Mitchell ES; Haigney MC
    Int J Cardiol; 2006 Nov; 113(2):239-41. PubMed ID: 16386810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Torsade de pointes during anti-arrhythmia treatment with amiodarone].
    Schlienger RG; Haefeli WE; Lüscher TF
    Schweiz Rundsch Med Prax; 1993 Feb; 82(6):173-5. PubMed ID: 7679520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Torsade de pointes: a severe and unknown adverse effect in indoramin self-poisoning.
    Nisse P; Soubrier S; Saulnier F; Mathieu-Nolf M
    Int J Cardiol; 2009 Apr; 133(2):e73-5. PubMed ID: 18191476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Female preponderance in ibutilide-induced torsade de pointes.
    Gowda RM; Khan IA; Punukollu G; Vasavada BC; Sacchi TJ; Wilbur SL
    Int J Cardiol; 2004 Jun; 95(2-3):219-22. PubMed ID: 15193823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improvement of amisulpride-induced extrapyramidal symptoms with quetiapine.
    Jagadheesan K; Muirhead D
    Aust N Z J Psychiatry; 2004 Jul; 38(7):560. PubMed ID: 15255830
    [No Abstract]   [Full Text] [Related]  

  • 34. Urinary incontinence associated with amisulpride.
    Mendhekar D; Lohia D
    World J Biol Psychiatry; 2009; 10(4 Pt 3):1045-6. PubMed ID: 18609424
    [No Abstract]   [Full Text] [Related]  

  • 35. ['Cardiac ballet' with and without amiodarone].
    Balestra B; Hess T
    Schweiz Med Wochenschr; 1993 Jan; 123(1-2):20-5. PubMed ID: 8421775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. QT interval prolongation, torsade de pointes and renal disease.
    Patanè S; Marte F; Di Bella G; Currò A; Coglitore S
    Int J Cardiol; 2008 Nov; 130(2):e71-3. PubMed ID: 18255176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Torsade de pointes associated with the administration of intravenous haloperidol.
    Hassaballa HA; Balk RA
    Am J Ther; 2003; 10(1):58-60. PubMed ID: 12522522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methadone-induced torsade de pointes in a patient with normal baseline QT interval.
    Almehmi A; Malas AM; Yousufuddin M; Rosencrance JG
    W V Med J; 2004; 100(4):147-8. PubMed ID: 15471174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amisulpride-induced tardive dystonia: a case report.
    Guriz O; Ekinci AE; Orsel S; Ekinci O
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):412-3. PubMed ID: 19944732
    [No Abstract]   [Full Text] [Related]  

  • 40. A case series of drug-induced long QT syndrome and Torsade de Pointes.
    Tong KL; Lau YS; Teo WS
    Singapore Med J; 2001 Dec; 42(12):566-70. PubMed ID: 11989578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.